This leads to inhibition of CD8+T cell activity, promotion of nasopharyngeal carcinoma tumor growth in mice, and evasion of T cell immunity by nasopharyngeal carcinoma cells (341). The gene discussed is CD8A; the disease is nasopharyngeal carcinoma.